Needham & Company LLC reaffirmed their buy rating on shares of ZimVie (NASDAQ:ZIMV – Free Report) in a report issued on Thursday morning,Benzinga reports. The firm currently has a $23.00 price target on the stock.
ZimVie Stock Down 1.7 %
Shares of ZimVie stock opened at $12.88 on Thursday. ZimVie has a 1 year low of $12.25 and a 1 year high of $22.40. The business has a 50-day moving average of $13.75 and a two-hundred day moving average of $14.78. The company has a market capitalization of $355.48 million, a P/E ratio of -0.98 and a beta of 2.10. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38.
ZimVie (NASDAQ:ZIMV – Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The company had revenue of $111.52 million during the quarter, compared to the consensus estimate of $113.67 million. As a group, equities analysts predict that ZimVie will post 0.6 EPS for the current year.
Institutional Investors Weigh In On ZimVie
ZimVie Company Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Stories
- Five stocks we like better than ZimVie
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Retail Stocks Investing, Explained
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.